HomeSUNPHARMA • NSE
add
Sun Pharmaceutical Industries Ltd
Nakaraang pagsara
₹1,780.00
Sakop ng araw
₹1,768.05 - ₹1,814.95
Sakop ng taon
₹1,184.50 - ₹1,960.35
Market cap
4.32T INR
Average na Volume
1.62M
P/E ratio
39.15
Dividend yield
0.75%
Primary exchange
NSE
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 132.91B | 9.01% |
Gastos sa pagpapatakbo | 74.12B | 8.61% |
Net na kita | 30.40B | 27.98% |
Net profit margin | 22.87 | 17.40% |
Kita sa bawat share | 12.70 | 28.28% |
EBITDA | 38.25B | 18.70% |
Aktuwal na % ng binabayarang buwis | 15.74% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 201.22B | 35.66% |
Kabuuang asset | 881.16B | 10.92% |
Kabuuang sagutin | 187.36B | 15.34% |
Kabuuang equity | 693.80B | — |
Natitirang share | 2.39B | — |
Presyo para makapag-book | 6.17 | — |
Return on assets | — | — |
Return on capital | 11.19% | — |
Cash Flow
Net change in cash
| (INR) | Set 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 30.40B | 27.98% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries across the globe. It is the largest pharmaceutical company in India and the fourth largest specialty generic pharmaceutical company in the world. The products cater to a vast range of therapeutic segments covering psychiatry, anti-infectives, neurology, cardiology, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynecology, respiratory, oncology, dental and nutritionals. Wikipedia
Itinatag
1983
Headquarters
Website
Mga Empleyado
43,000
